Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biomarkers for Psychosis, Are We There Yet? Umbrella Review of 1478 Biomarkers

  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • Estradé, Andrés|||0000-0001-6871-5932
  • Solanes, Aleix|||0000-0002-2491-200X
  • Ramella-Cravaro, Valentina
  • Garcia-Leon, Maria Angeles
  • Diego-Adeliño, Javier de|||0000-0001-9708-2441
  • Molins, Conrad
  • Fung, Eric
  • Valentí, Marc
  • Anmella, Gerard|||0000-0002-6798-4054
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Oliver, Dominic|||0000-0002-8920-3407
  • Vieta, Eduard|||0000-0002-0548-0053
  • Radua, Joaquim|||0000-0003-1240-5438
  • Fusar-Poli, Paolo|||0000-0003-3582-6788
This umbrella review aims to comprehensively synthesize the evidence of association between peripheral, electrophysiological, neuroimaging, neuropathological, and other biomarkers and diagnosis of psychotic disorders. We selected systematic reviews and meta-analyses of observational studies on diagnostic biomarkers for psychotic disorders, published until February 1, 2018. Data extraction was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Evidence of association between biomarkers and psychotic disorders was classified as convincing, highly suggestive, suggestive, weak, or non-significant, using a standardized classification. Quality analyses used the Assessment of Multiple Systematic Reviews (AMSTAR) tool. The umbrella review included 110 meta-analyses or systematic reviews corresponding to 3892 individual studies, 1478 biomarkers, and 392 210 participants. No factor showed a convincing level of evidence. Highly suggestive evidence was observed for transglutaminase autoantibodies levels (odds ratio [OR] = 7.32; 95% CI: 3.36, 15.94), mismatch negativity in auditory event-related potentials (standardized mean difference [SMD] = 0.73; 95% CI: 0.5, 0.96), P300 component latency (SMD = -0.6; 95% CI: -0.83, -0.38), ventricle-brain ratio (SMD = 0.61; 95% CI: 0.5, 0.71), and minor physical anomalies (SMD = 0.99; 95% CI: 0.64, 1.34). Suggestive evidence was observed for folate, malondialdehyde, brain-derived neurotrophic factor, homocysteine, P50 sensory gating (P50 S2/S1 ratio), frontal N -acetyl-aspartate, and high-frequency heart rate variability. Among the remaining biomarkers, weak evidence was found for 626 and a non-significant association for 833 factors. While several biomarkers present highly suggestive or suggestive evidence of association with psychotic disorders, methodological biases, and underpowered studies call for future higher-quality research.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Theory of mind in schizophrenia through a clinical liability approach, a sib-pair study

  • Giralt López, Maria|||0000-0003-4555-152X
  • Miret, S.
  • Campanera, Silvia
  • Moreira, Marco Antonio
  • Sotero-Moreno, A.
  • Krebs, Marie Odile|||0000-0002-4715-9890
  • Fañanás Saura, Lourdes
  • Fatjó-Vilas, Mar|||0000-0001-9963-6241
Consistent findings indicate that Theory of Mind (ToM) is impaired in schizophrenia (SZ). To investigate whether such deficits are trait- or state-dependent, we investigated if ToM is modified by clinical liability markers (such as basic symptoms and psychotic-like experiences), focusing on the analysis of unaffected siblings of individuals diagnosed with SZ. The study included a total of 65 participants: 38 patients diagnosed with a schizophrenia-spectrum disorder and 27 healthy siblings. ToM was assessed using the Hinting Task (HT), Basic symptoms with The Frankfurt Complaint Questionnaire (FCQ), Psychotic-like-experiences with the Community Assessment of Psychic Experiences (CAPE) and Family history with the Family Interview for Genetic Studies. First, a comparison of HT performance between patients and siblings (linear mixed model adjusted for age, sex and Intelligence Quotient (IQ)) showed that patients presented lower scores than siblings (p = 0.022). These differences did not remain significant after adjusting for clinical vulnerability markers. Second, within siblings, linear regression analyses (adjusted for age, sex, IQ and family history) showed that higher FCQ Depressiveness and CAPE negative scores were related to poorer ToM performance (p = 0.007 and p = 0.032, respectively). Our findings suggest that clinical liability markers are valuable for delineating variations in ToM capabilities within healthy individuals. Moreover, our results indicate that ToM deficits are not solely linked to SZ but also extend to its clinical vulnerability, suggesting that ToM could serve as an endophenotypic marker. This implies that ToM could help distinguish particularly susceptible individuals from a population at risk, such as those with a genetic predisposition (siblings).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Early structural brain abnormalities in borderline personality disorder

  • Salgado-Pineda, Pilar|||0000-0001-7720-0885
  • Ferrer Vinardel, Marc|||0000-0002-1283-8578
  • Calvo, Natalia|||0000-0002-6888-3781
  • Costa, Xavier|||0000-0002-8899-9079
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Tarragona, Brenda
  • Duque-Yemail, Juan|||0000-0002-1346-5996
  • Vaciana-Verdaguer, Cristina
  • Rué, Àlex|||0000-0002-3879-0170
  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • Ferrer, Silvia
  • Salvador, Raymond|||0000-0001-5557-1562
  • McKenna, Peter J.
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
Structural imaging studies of borderline personality disorder (BPD) have identified regions of reduced and increased cortical volume, as well as volume reductions in the hippocampus and amygdala, although with considerable variability across studies. Examining adolescent patients with the disorder can reduce potential confounding effects such as later development of affective and other comorbid disorders. Fifty-one adolescents (48 females, 3 males) with BPD and without comorbid disorders and with 43 matched healthy controls underwent whole-brain voxel-based morphometry (VBM). Hippocampus and amygdala volumes were also measured using conventional volumetric techniques. At a threshold of p = 0.05 corrected, the BPD patients exhibited a cluster of grey matter volume reduction in the left temporo-parietal junction (TPJ). No evidence of volume reductions in the hippocampus or amygdala was found. Comparison between the female-only subsamples (48 BPD patients and 37 controls) yielded similar findings. The cluster of volume reduction in the left TPJ continued to be seen in 37 drug-naïve patients. According to this study, the initial stage of BPD is characterized by decreased grey matter volume in the left TPJ, a region that is implicated in various aspects of social cognition. Given that the volume loss was detected prior to adulthood, in individuals without comorbidities, and among patients who were drug naïve, this finding could be significant for understanding the developmental trajectory of the disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Brain functional abnormality in drug naïve adolescents with borderline personality disorder during self- and other-reflection

  • Salgado-Pineda, Pilar|||0000-0001-7720-0885
  • Ferrer Massot, Marc|||0000-0003-0046-1301
  • Duque-Yemail, Juan|||0000-0002-1346-5996
  • Costa, Xavier|||0000-0002-8899-9079
  • Rué, Àlex|||0000-0002-3879-0170
  • Pérez-Rodríguez, Violeta|||0000-0002-2485-3054
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • Salvador, Raymond|||0000-0001-5557-1562
  • McKenna, Peter J.
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Calvo, Natalia|||0000-0002-6888-3781
  • Veciana-Verdaguer, Cristina
A disturbed sense of identity is one of the major features of borderline personality disorder (BPD), which manifests early in the course of the disorder, and is potentially examinable using functional imaging during tasks involving self-reflection. Twenty-seven medication-naïve adolescent female patients with BPD, who had no psychiatric comorbidities, and 28 matched healthy female controls underwent fMRI while answering questions either about themselves or acquaintances. Control conditions consisted of answering questions involving factual knowledge and a low-level baseline (cross fixation). When self-reflection was compared to fact processing, BPD patients exhibited reduced activation in the right dorsolateral prefrontal cortex (DLPFC), as well as in the left parietal and calcarine cortex and the right precuneus. In contrast, other-reflection was associated with relatively lower activation in the medial frontal cortex in BPD patients, with further analysis revealing that this change reflected a failure of de-activation during the fact processing condition. There were no differences between the BPD patients and controls when self- and other-processing was examined against low-level baseline. This study provides evidence of reduced DLPFC activation during self-reflection in adolescent females with BPD, which may reflect diminished top-down cognitive control of this process, but not other-reflection in the disorder.